Pharmaceutical Marketing Supported by Deceitful Clinical Research
Alex Pietrowski, Staff
Waking Times
The business model for bringing lucrative new pharmaceutical drugs to market includes very robust marketing budgets, and 9 out of 10 pharmaceutical companies spend more on advertising than they do on research. And why not? Americans spend an average of $1000 per person, per year on pharmaceutical drugs, and the effort to capture these dollars is leading more companies to fast track or even fabricate the research involved in bringing a new drug to market.
Here’s a look at how much the largest pharmaceutical companies spent on marketing vs. expenditures on research and development in 2013:
The push to push drugs on the American people is heavily dependent on the ability to produce favorable research that backs any and all claims that marketing departments wish to make about the drug in order for it to stand out in the competitive field of retail drug sales. Thanks to the admissions of some of the most influential people in this industry, we are now discovering that much of the research being presented in support of many new drugs, vaccines and procedures is fake, and even leading medical journals are agreeing that big pharma manipulates medical research at the expense of public health.Consider the following statements and admissions by very important people who are close enough to the inner workings of the industry to know for sure just how bad the public is being deceived.
In 2015, the editor of one of the world’s most respected medical journals, The Lancet, went public with his admission that research fraud was rampant in the field of medical clinical research:
The following clip is from the documentary ‘One More Girl,’ about the startlingly damaging effects of the Gardasil vaccine. In the clip, former Pfizer Vice President, Dr. Peter Rost candidly discusses the truth about the influence of money in the pharmaceutical industry. Dr. Rost wrote the book, The Whistleblower, Confessions of a Healthcare Hitman to contribute to the growing body of evidence that blows the whistle on corporate fraud within the medical establishment.
Dependence on so-called clinical research to support the claims made by pharmaceutical marketing departments is proving to be dangerously misled. Can the public trust the medical establishment to bring effective and safe medicines to market? Increasingly, the evidence is suggesting that it is not.
Read More Here
